PT UBC Medical Indonesia Tbk (ISX:LABS) EPS (Diluted): Rp (TTM As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is PT UBC Medical Indonesia Tbk EPS (Diluted)?

PT UBC Medical Indonesia Tbk ISX:LABS EPS (Diluted) is Rp as of . 20. The stock has 2 warning signs investors should review.

PT UBC Medical Indonesia Tbk's Earnings per Share (Diluted) for the six months ended in . 20 was Rp0.00.

PT UBC Medical Indonesia Tbk's EPS (Basic) for the six months ended in . 20 was Rp0.00.

PT UBC Medical Indonesia Tbk's EPS without NRI for the six months ended in . 20 was Rp0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

PT UBC Medical Indonesia Tbk  (ISX:LABS) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

PT UBC Medical Indonesia Tbk EPS (Diluted) Related Terms

PT UBC Medical Indonesia Tbk EPS (Diluted) Historical Data

* Premium members only.

The historical data trend for PT UBC Medical Indonesia Tbk's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT UBC Medical Indonesia Tbk EPS (Diluted) Chart

PT UBC Medical Indonesia Tbk Annual Data
Trend
EPS (Diluted)

PT UBC Medical Indonesia Tbk Semi-Annual Data
EPS (Diluted)

ISX:LABS vs ABT, SYK, MDT: EPS (Diluted) Comparison

For the Medical Devices subindustry, PT UBC Medical Indonesia Tbk's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PT UBC Medical Indonesia Tbk PE Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, PT UBC Medical Indonesia Tbk's PE Ratio distribution charts can be found below:

* The bar in red indicates where PT UBC Medical Indonesia Tbk's PE Ratio falls into.


PT UBC Medical Indonesia Tbk EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

PT UBC Medical Indonesia Tbk's Diluted EPS for the fiscal year that ended in . 20 is calculated as

Diluted EPS (A: . 20 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-)/0
=

PT UBC Medical Indonesia Tbk's Diluted EPS for the quarter that ended in . 20 is calculated as

Diluted EPS (Q: . 20 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-)/0
=

Frequently Asked Questions Learn more about EPS (Diluted) →
What does a EPS (Diluted) of Rp mean?
PT UBC Medical Indonesia Tbk (ISX:LABS) has a EPS (Diluted) of Rp as of . 20. Earnings per share (diluted) equals net income divided by the diluted average shares outstanding. View historical data on PT UBC Medical Indonesia Tbk and its competitors.
Is PT UBC Medical Indonesia Tbk's EPS (Diluted) too high?
PT UBC Medical Indonesia Tbk's current EPS (Diluted) is Rp.
How does PT UBC Medical Indonesia Tbk's EPS (Diluted) compare to ABT and SYK?
PT UBC Medical Indonesia Tbk's EPS (Diluted) of Rp can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Diluted) for a Medical Devices & Instruments company?
A good EPS (Diluted) depends on the Medical Devices & Instruments industry context. However, EPS (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Diluted) mean?
A high EPS (Diluted) can signal that a stock is expensive relative to its fundamentals. Earnings per share (diluted) equals net income divided by the diluted average shares outstanding. View historical data on PT UBC Medical Indonesia Tbk and its competitors. PT UBC Medical Indonesia Tbk's current EPS (Diluted) is Rp. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT UBC Medical Indonesia Tbk stock overvalued right now?
PT UBC Medical Indonesia Tbk (ISX:LABS) has a current EPS (Diluted) of Rp. The current EPS (Diluted) is Rp. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Diluted) calculated?
EPS (Diluted) is calculated from a company's financial statements. For PT UBC Medical Indonesia Tbk (ISX:LABS), the current EPS (Diluted) is Rp as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PT UBC Medical Indonesia Tbk Business Description

Address Jl. Rawagelam V, Blok L, No Kav 11-13, Kantor Pusat, Kawasan Industri Pulogadung, Kel. Jatinegara Kec. Cakung, Jakarta Timur, Jakarta, IDN
PT UBC Medical Indonesia Tbk is a distribution company. It engages in wholesale of Laboratory Equipment, Pharmaceutical Equipment, and Medical Equipment for Humans and animals, which includes the wholesale of laboratory equipment, pharmaceutical equipment, and medical equipment. It divides its main marketed medical equipment products into two categories Instruments, in the form of equipment, machines, and analyzers, are used in laboratories. The function of instruments is to process specimens or biological samples to measure and examine the levels of certain substances/contents; and Consumables include single-use medical devices used for treatment or health examinations and Reagents include chemical reagents used in laboratory tests to detect, measure, examine, & produce other substances.